Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emma L. Hiscutt"'
Autor:
Dale Jobson, Benjamin Roffey, Christopher Arnold, Anthony Azzi, Alison Button‐Sloan, Tamara Dawson, Pablo Fernandez‐Penas, Paul Fishburn, David E. Gyorki, Emma L. Hiscutt, Valerie Jakrot, Alister Lilleyman, Alistair Lochhead, Georgina V. Long, Sonia Mailer, Graham Mann, Christopher J. McCormack, Jim Muir, George F. Pratt, Richard A. Scolyer, Mark Shackelton, Stephen Shumack, H. Peter Soyer, Chin‐Guan Tan, Angela Webb, John Zalcberg, Rachael Morton, Victoria Mar
Publikováno v:
The Australasian journal of dermatologyREFERENCES. 63(3)
Clinical quality registries aim to identify significant variations in care and provide anonymised feedback to institutions to improve patient outcomes. Thirty-six Australian organisations with an interest in melanoma, raised funds through three conse
Publikováno v:
Leukemia & Lymphoma. 62:992-994
Check point inhibitors stimulate the immune systems antitumour response by impairing T cell inhibitory signaling pathways [1]. Ipilimumab is a widely used check point inhibitor which acts on cytoto...
Autor:
Michael A. Henderson, Albert Tiong, Emma L Hiscutt, Angela Webb, Michelle Sy Goh, Phillip Tran, Vanessa Estall, William K. Murray, Edmund Wee, Catherine Mitchell, Christopher McCormack
Publikováno v:
The Australasian journal of dermatology. 59(4)
Background/objectives To describe the characteristics, subsequent management and outcomes of patients referred for further management following Mohs micrographic surgery (MMS) for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Methods
Autor:
Simone Fulda, Jane L. Armstrong, Shaun Martin, Ryan Kerr, Andrew Harbottle, Emma L. Hiscutt, Mark A. Birch-Machin, Penny E. Lovat, D. S. Hill, Christopher P.F. Redfern
Publikováno v:
Journal of Investigative Dermatology. 130(9):2250-2258
Melanoma remains notoriously resistant to current chemotherapeutics, leaving an acute need for novel therapeutic approaches. The aim of this study was to determine the prognostic and therapeutic significance of X-linked inhibitor of apoptosis protein